
Journal of Extracellular Vesicles, Год журнала: 2024, Номер 13(9)
Опубликована: Сен. 1, 2024
Язык: Английский
Journal of Extracellular Vesicles, Год журнала: 2024, Номер 13(9)
Опубликована: Сен. 1, 2024
Язык: Английский
Pharmaceutics, Год журнала: 2024, Номер 16(6), С. 709 - 709
Опубликована: Май 24, 2024
Of all the numerous nanosized extracellular vesicles released by a cell, endosomal-originated exosomes are increasingly recognized as potential therapeutics, owing to their inherent stability, low immunogenicity, and targeted delivery capabilities. This review critically evaluates transformative of exosome-based modalities across pharmaceutical precision medicine landscapes. Because precise biomolecular cargo delivery, posited ideal candidates in drug enhancing regenerative strategies, advancing diagnostic technologies. Despite significant market growth projections exosome therapy, its utilization is encumbered substantial scientific regulatory challenges. These include lack universally accepted protocols for isolation complexities associated with navigating environment, particularly guidelines set forth U.S. Food Drug Administration (FDA). presents comprehensive overview current research trajectories aimed at addressing these impediments discusses prospective advancements that could substantiate clinical translation exosomal therapies. By providing analysis both capabilities hurdles therapeutic applications, this article aims inform direct future paradigms, thereby fostering integration systems into mainstream practice.
Язык: Английский
Процитировано
19Journal of Extracellular Vesicles, Год журнала: 2023, Номер 12(10)
Опубликована: Окт. 1, 2023
The widely overlapping physicochemical properties of lipoproteins (LPs) and extracellular vesicles (EVs) represents one the main obstacles for isolation characterization these pervasive biogenic lipid nanoparticles. We herein present application an atomic force microscopy (AFM)-based quantitative morphometry assay to rapid nanomechanical screening mixed LPs EVs samples. method can determine diameter mechanical stiffness hundreds individual nanometric objects within few hours. obtained diameters are in accord with those measured via cryo-electron (cryo-EM); assignment specific readout each object enables simultaneous discrimination co-isolated even if they have size distributions. all classes shown be characterised by combinations stiffness, thus making it possible estimate their relative abundance EV/LP samples terms stoichiometric ratio, surface area volume. As a side finding, we show how behaviour LP is correlated distinctive structural features revealed cryo-EM. described approach label-free, single-step relatively quick perform. Importantly, used analyse which prove very challenging assess several established techniques due ensemble-averaging, low sensibility small particles, or both, providing useful tool quickly assessing purity isolates including plasma- serum-derived preparations.
Язык: Английский
Процитировано
26Journal of Extracellular Vesicles, Год журнала: 2023, Номер 12(8)
Опубликована: Июль 25, 2023
Extracellular vesicles (EVs) are increasingly gaining interest as biomarkers and therapeutics. Accurate sizing quantification of EVs remain problematic, given their nanometre size range small scattering cross-sections. This is compounded by the fact that common EV isolation methods result in co-isolation particles with comparable features. Especially blood plasma, similarly-sized lipoproteins outnumber to a great extent. Recently, interferometric nanoparticle tracking analysis (iNTA) was introduced particle method enables determining refractive index nanoparticles high sensitivity precision. In this work, we apply iNTA differentiate between lipoproteins, compare its performance conventional (NTA). We show can accurately quantify artificial EV-lipoprotein mixtures plasma-derived samples varying complexity. Conventional NTA could not report on numbers, it able distinguish from lipoproteins. has potential become new standard for label-free characterization suspension.
Язык: Английский
Процитировано
25Nature Reviews Bioengineering, Год журнала: 2024, Номер unknown
Опубликована: Ноя. 12, 2024
Язык: Английский
Процитировано
9Advanced Science, Год журнала: 2024, Номер 11(29)
Опубликована: Май 31, 2024
Abstract Extracellular vesicles (EVs), crucial mediators of cell‐to‐cell communication, hold significant diagnostic potential due to their ability concentrate protein biomarkers in bodily fluids. However, challenges isolating EVs from biological specimens hinder widespread use. The preferred strategy involves direct analysis, integrating isolation and analysis solutions, with immunoaffinity methods currently dominating. Yet, the heterogeneous nature poses challenges, as proposed markers may not be universally present thought, raising concerns about biomarker screening reliability. This issue extends EV‐mimics, where conventional lack applicability. Addressing these study reports on Membrane Sensing Peptides (MSP) pan‐vesicular affinity ligands for both non‐canonical analogs, streamlining capture phenotyping through Single Molecule Array (SiMoA). MSP enable circulating EVs, eliminating need prior isolation. Demonstrating clinical translation, technology detects an EV‐associated epitope signature serum plasma, distinguishing myocardial infarction stable angina. Additionally, allow tetraspanin‐lacking Red Blood Cell‐derived overcoming limitations associated antibody‐based methods. Overall, work underlines value complementary tools antibodies, advancing EV diagnostics beyond, marking first‐ever peptide‐based application SiMoA technology.
Язык: Английский
Процитировано
7European Journal of Pharmaceutics and Biopharmaceutics, Год журнала: 2024, Номер 197, С. 114233 - 114233
Опубликована: Фев. 20, 2024
Язык: Английский
Процитировано
6ACS Nano, Год журнала: 2025, Номер unknown
Опубликована: Апрель 24, 2025
Single extracellular vesicle (EV) research holds the potential to revolutionize our understanding of cellular communication and enable breakthroughs in diagnostics therapeutics. However, lack a clear, consensus-driven definition single EV has led methodological inconsistencies, overgeneralized interpretations, and, some cases, misleading claims. In this perspective, we propose framework for defining research, critique current challenges misconceptions field, discuss its implications biomedical applications. We argue that precise experimental design, rigorous validation, interdisciplinary collaboration approaches are needed establish as cornerstone precision medicine.
Язык: Английский
Процитировано
0International Journal of Pharmaceutics, Год журнала: 2025, Номер unknown, С. 125667 - 125667
Опубликована: Апрель 1, 2025
Aerobic vaginitis is an infectious disease characterized by the overgrowth of abnormal vaginal microflora. Conventional local dosage forms are not always effective, due to their inadequate drug release and residence time within cavity. Therefore, this study aimed develop azithromycin (AZT)-loaded liposomes, coated with two mucoadhesive polymers, chitosan (CS) sodium hyaluronate (HYA), increase thedrug's stay at site infection control its release. Liposomes were developed through thin film hydration method followed extrusion subsequently added polymer solution. Later, they size, surface charge, morphology, encapsulation efficiency. Furthermore, properties behavior investigated different pH values, e.g., 4.5 7.4, mimicking physiological pathological conditions, respectively. Finally, antimicrobial tests in vitro permeation studies carried out. Results showed size charge variations LP respect uncoated ones, confirming success coating process. possessed a good capacity encapsulate drug. Among all formulations, CS-LP demonstrated superior greatest both tested pHs, as well highest accumulation inside tissue, maintaining same AZT effect. Overall, could be proposed promising nanocarrier for delivery, virtue ability achieve locally sustained drug, helping lower administration frequency, consequently improving treatment efficacy.
Язык: Английский
Процитировано
0Journal of Extracellular Vesicles, Год журнала: 2024, Номер 13(10)
Опубликована: Окт. 1, 2024
Abstract Escherichia coli A0 34/86 (EcO83) is a probiotic strain used in newborns to prevent nosocomial infections and diarrhoea. This bacterium stimulates both pro‐ anti‐inflammatory cytokine production its intranasal administration reduces allergic airway inflammation mice. Despite benefits, there are concerns about the use of live bacteria due potential systemic gene transfer. Extracellular vesicles (EVs) derived from EcO83 (EcO83‐EVs) might offer safer alternative bacteria. study characterizes EcO83‐EVs investigates their interaction with host cells, highlighting as postbiotic therapeutics. were isolated, purified, characterised following Minimal Information Studies Vesicles (MISEV) guidelines. Ex vivo studies conducted human nasal epithelial cells showed that increased expression proteins linked oxidative stress inflammation, indicating an effective between EVs cells. Further mice demonstrated interact nasal‐associated lymphoid tissue, internalised by macrophages, stimulate neutrophil recruitment lung. Mechanistically, activate NF‐κΒ signalling pathway, resulting nitric oxide production. demonstrate significant bacteria, offering option for therapeutic applications. research required explore clinical use, particularly mucosal vaccination targeted immunotherapy strategies.
Язык: Английский
Процитировано
3Research Square (Research Square), Год журнала: 2025, Номер unknown
Опубликована: Фев. 27, 2025
Язык: Английский
Процитировано
0